Amgen announced positive topline Phase 2 results from the CodeBreaK 100 clinical study, evaluating sotorasib (proposed INN for AMG 510)...
Amgen, Cytokinetics, Incorporated and Servier announced topline results from GALACTIC-HF, a Phase 3 pivotal clinical trial of omecamtiv mecarbil in...
Bristol Myers Squibb announced detailed results from True North, a pivotal, placebo-controlled Phase 3 trial evaluating oral Zeposia (ozanimod) as...
CStone Pharmaceuticals and Pfizer Investment Co. Ltd. and Pfizer Corporation Hong Kong Limited announced the formation of a strategic collaboration...
Antengene Corporation, a leading innovative biopharmaceutical company, and WuXi Biologics (WuXi Bio) announced that they have signed a strategic cooperation...
Eli Lilly and Company and the Bill & Melinda Gates Foundation, as part of the COVID-19 Therapeutics Accelerator, have entered...
The second part of the 2020 CPhI Annual Report predicts significant market changes for digital adoption and global generic consumption...
AstraZeneca’s long-acting antibody (LAAB) combination, AZD7442, will advance into two Phase III clinical trials in more than 6,000 participants at...
Pfizer and BioNTech announced the initiation of a rolling submission to the EMA for BNT162b2, the lead candidate from the...
The Coalition for Epidemic Preparedness Innovations (CEPI) has partnered with five clinical sample testing labs to create a centralized global...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
